In addition to JPH-203, other drugs currently in preclinical and clinical trials targeting LAT1 include IPA-131, QBS-10072S, TLX101-CDx, 124I-ACD-101, 211At-TLX-102, OKY-034, [18F] NKO-028 (Table 1)
While all three amino acids are necessary to make glutathione, the rate at which your body produces this antioxidant generally depends on how much cysteine is available
In several cases, durable metabolic benefits appear to require co-administration with specific dietary substrates or prebiotics, such as inulin-based synbiotics or chemically modified resistant starch, highlighting that both microbial composition and nutrient context are critical for colonization stability and functional output (Wang et al., 2025)
But yeah, I mean, you hear that all the time that people inject something, and there was more in it than they thought
Real-Life Stories Many patients using the combination therapy have shared stories of transformative weight loss and improved health